Gene · 4300
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How chromosomal translocations arise to cause cancer: Gene proximity, trans-splicing, and DNA end joining. | iScience | 2023 | 37378346 | PubTator, text mining | PubMed |
| Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine-Panobinostat Combination. | Cancers (Basel) | 2023 | 37370721 | PubTator, text mining | PubMed |
| CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression. | Genome Biol | 2023 | 37353834 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. | Cancers (Basel) | 2023 | 37345204 | PubTator, text mining | PubMed |
| Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment. | Cancers (Basel) | 2023 | 37345170 | PubTator, text mining | PubMed |
| PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia. | Br J Cancer | 2023 | 37340093 | PubTator, text mining | PubMed |
| The genesis of human hematopoietic stem cells. | Blood | 2023 | 37339578 | PubTator, text mining | PubMed |
| miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease. | Mol Neurobiol | 2023 | 37329382 | PubTator, text mining | PubMed |
| Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development. | Front Cell Dev Biol | 2023 | 37325571 | PubTator, text mining | PubMed |
| Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo. | Front Pharmacol | 2023 | 37324449 | PubTator, text mining | PubMed |
| The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment. | Blood | 2023 | 37319434 | PubTator, text mining | PubMed |
| Applications of long-read sequencing to Mendelian genetics. | Genome Med | 2023 | 37316925 | PubTator, text mining | PubMed |
| AF9 targets acetyl-modified STAT6 to diminish purine metabolism and accelerate cell apoptosis during metastasis. | Cell Death Differ | 2023 | 37308587 | PubTator, text mining | PubMed |
| Super-enhancer-associated gene CAPG promotes AML progression. | Commun Biol | 2023 | 37296281 | PubTator, text mining | PubMed |
| The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia. | Exp Hematol | 2023 | 37295550 | PubTator, text mining | PubMed |
| Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments. | Cancer Biol Ther | 2023 | 37272701 | PubTator, text mining | PubMed |
| Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility. | Hum Genomics | 2023 | 37270590 | PubTator, text mining | PubMed |
| Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease. | Front Immunol | 2023 | 37266442 | PubTator, text mining | PubMed |
| New molecular targets in Hodgkin and Reed-Sternberg cells. | Front Immunol | 2023 | 37266436 | PubTator, text mining | PubMed |
| Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT. | J Hematol Oncol | 2023 | 37248463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4300/papers?page=11